Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February–May 2021 is a research paper published in The Journal of Infectious Diseases (2021). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →US Centers for Disease Control and Prevention
Grant: U01IP001034–U01IP001039
National Institutes of Health
Grant: ULTR001857
NCIRD CDC HHS
Grant: U01 IP001035
NCATS NIH HHS
Grant: UL1 TR001857
ACL HHS
Grant: U01IP001034
NCIRD CDC HHS
Grant: U01 IP001039
FWCI
0.19
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals